Hoppa till innehållet

Redeye: Lifco Q1 2024 - Cyclicality materialised

Redeye updates its estimates and valuation following Lifco releasing its Q1 2024 report, which came in broadly below our estimates. We judge that positives from the report include Dental and Systems Solutions performing decently. Notable negatives include Demolition & Tools’ deterioration exceeding what we had pencilled in. Overall, we lower our 2024e estimates but leave our valuation largely unchanged.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking.www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera